Cspc Pharmaceutical | 1093 - Cash And Equivalent

Stock Price
7.49
Daily Change
-0.09 -1.19%
Monthly
-16.87%
Yearly
18.89%
Q2 Forecast
7.62

Cspc Pharmaceutical reported CNY7.57B in Cash and Equivalent for its fiscal quarter ending in June of 2025.





Cash And Equivalent Change Date
Akebia Therapeutics USD 162.64M 22.2M Mar/2026
Alaunos Therapeutics USD 354K 1.03M Mar/2026
Avita Medical AUD 10.24M 1.98M Dec/2025
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
Dianthus Therapeutics USD 627.67M 576.58M Mar/2026
Ionis Pharmaceuticals USD 1.92B 758M Mar/2026
IQVIA Holdings USD 1.95B 33M Mar/2026
Jiangsu Hengrui CNY 40.96B 591.41M Dec/2025
Kangmei Pharma CNY 1.18B 278M Sep/2025
Moderna USD 1.91B 687M Mar/2026
Organon & Co USD 1.12B 542M Mar/2026
Revvity USD 860.32M 59.54M Mar/2026
Sh Fosun Pharma CNY 13.1B 1.63B Dec/2025
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Tectonic Therapeutic USD 236.89M 16.9M Mar/2026
Viatris USD 1.8B 481.8M Mar/2026
Wuxi Apptec CNY 35.91B 773.93M Mar/2026
Xeris Pharmaceuticals USD 111.75M 708K Mar/2026
Zz Pientze Pharmaceu CNY 1.96B 186.63M Mar/2026